ARWR
SHORT CANDIDATEMeanRevComposite
21.30
Technical
0.60
Fundamental
28.20
Rank
—
Price
58.13
Hurst
0.09
As of
Oct 14, 2026
Daily
Arrowhead Pharmaceuticals Inc
HEALTHCAREBIOTECHNOLOGYArrowhead Pharmaceuticals operates as a drug development firm focused on treating difficult-to-manage diseases, with operations based in Pasadena, California. The company works to create therapeutic solutions for medical conditions that have proven resistant to existing treatment approaches.
Market cap
$8.2B
P/E (trailing)
—
P/E (forward)
111.11
PEG ratio
-1.32
Dividend yield
—
Beta
1.30
52w range
36.57 – 95.49
Return on equity
-55.20%
Profit margin
-47.80%
Revenue growth
+171.00%
Earnings growth
+9.80%
Price history
1Y: 58.13 (+64.2%) · range 35.41–89.59
Cycle position
14/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 98 · STRONG SETUP · exit proximity 0
Conviction
54/ 100 · maturity 43%
VScore.2230
Buildup.2638
EMA entry setup.3298
Fundamentals.1928
Volume profile
POC
74.17
Price vs POC
-21.6%
Overhead supply
100%
Runway
+26.3%
Value area 70.05–87.26 · 100% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trader-sentiment | 0.815 | Oct 14, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.